Background-Stroke in female first-degree relatives (FDRs) is a powerful risk factor for ischemic stroke in women, but its association with acute coronary syndromes (ACS) is unknown. Family history (FH) of stroke is omitted from existing myocardial infarction risk prediction tools, which perform less well in women than in men. Our objective was to study the sex-of-parent and sex-of-proband interactions for FH of stroke in ACS patients. Methods and Results-In a prospective, population-based study (Oxford Vascular Study) of all patients with ACS or stroke/transient ischemic attack, FH data for stroke and myocardial infarction were analyzed by sex of proband and FDRs, and coronary angiograms were reviewed, where available; 942 of 1058 ACS probands and 1015 of 1152 stroke/transient ischemic attack probands had complete FH data; 24.1% of ACS probands and 24.3% of stroke/transient ischemic attack probands had history of stroke in Ն1 FDR. Maternal stroke was more common than paternal stroke in female ACS probands (odds ration [OR], 2.53; 1.39 to 4.61) but not in male probands (OR, 0.92; 0.64 to 1.32) (difference-Pϭ0.004). Overall, female ACS probands were more likely to have female than male FDRs with stroke (OR, 2.09; 1.29 to 3.37), whereas the opposite trend was seen in male ACS probands (OR, 0.69; 0.50 to 0.97) (difference-Pϭ0.0002). However, there was no association between parental history of stroke and disease localization or presence of multivessel disease on coronary angiography. Conclusions-FH of stroke is as common in ACS patients as in stroke/transient ischemic attack patients and sex-of-parent/ sex-of-proband interactions are similar. Stroke in female FDRs may help to identify women at increased risk of ACS as well as ischemic stroke. (Circ Cardiovasc Genet. 2011;4:9-15.)
F amily history (FH) is a significant risk factor for both myocardial infarction (MI) 1,2 and stroke. 3, 4 Although arterial disease in one territory strongly predicts clinical events in other territories 5 and some shared heritability between acute coronary syndromes (ACS) and stroke is likely, 6 few studies have considered FH of stroke in ACS probands, 7 and none have been population-based or have fully investigated sex-of-parent/sexof-offspring interactions. FH of stroke is often not recorded in clinical practice, 8 perhaps because it is excluded in existing MI risk prediction tools. 9 -13 
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Importantly, FH of premature MI is associated with increased risk of MI 14 and cardiovascular risk factors, particularly in young women. 15 The Cardiovascular Health Study showed that sibling history of stroke was also associated with increased risk of MI and cardiovascular risk factors, but sex-specific effects remain unknown. 16 Despite having lower age-specific incidence of MI than men, women have higher case-fatality, and women with FH of MI demonstrate less risk awareness and worse lifestyle choices than men. 15 Twenty percent of all MI in women occurs in the absence of traditional risk factors, necessitating the development of specific MI risk prediction tools for women. 17 However, even QRISK, 18 which includes FH of premature MI, identified only 18% of women who had an MI over a 10-year period as "high-risk." 19 Improved understanding of the effect of FH of stroke may therefore improve risk prediction, particularly in women.
We have shown that heritability of ischemic stroke is greater in women than in men, with a 2-to 3-fold excess of affected mothers and affected sisters in female stroke probands, independent of traditional risk factors. 20 We also recently showed that maternal MI is a particularly important risk factor for MI in young women. 9 If some genes influence risk of both stroke and MI, FH of stroke may be more strongly associated with the etiology of MI in women than in men. We therefore conducted the first population-based study of sex-specific effects of FH of stroke in ACS, comparing with the effects of FH of stroke in stroke/transient ischemic attack (TIA).
Methods
The methods of the Oxford Vascular Study (OXVASC) have been published previously. 21 Briefly, OXVASC is an ongoing populationbased study of all incident or recurrent TIAs, strokes, ACS, and acute peripheral vascular events in a population of 91 106 people registered with 63 family physicians in Oxfordshire, United Kingdom. These general practices were originally selected to be representative of the urban and rural mix and the deprivation range of Oxfordshire as a whole. The OXVASC population had 94% white people, 3% Asian, 2% Chinese, and 1% Afro-Caribbean. Ascertainment combines prospective daily searches for acute events (hot pursuit) and retrospective searches of hospital-care and primary-care administrative and diagnostic coding data (cold pursuit). Multiple search methods ensure near complete ascertainment of all patients who seek medical attention after a vascular event. 21 All patients with a diagnosis of ACS, TIA, or stroke who were enrolled from April 1, 2002 , to September 30, 2008 , were eligible for the present study. OXVASC was approved by the local research ethics committee.
A physician assessed patients as soon as possible after the ischemic event and gathered clinical data using a structured questionnaire. Details of the presenting event and medical history were recorded from the patient, their relatives, family doctor, and hospital records. Detailed data on known vascular risk factors and any previous symptomatic vascular disease were also recorded. If the patient died before assessment, we obtained an eyewitness account of the clinical event and reviewed relevant medical records.
Information about any FH of stroke, MI, or vascular risk factors and about age at onset of disease in affected relatives (deceased or alive) was collated separately for the father, mother, brothers, and sisters (collectively termed first-degree relatives or FDRs) by use of a structured questionnaire. An inclusive definition of FH of MI was used in this study, including both fatal (62.2% of recorded parental MI) and nonfatal events (37.8%). FH of known primary intracranial hemorrhage or subarachnoid hemorrhage was not included in analysis of FH of ischemic stroke because they have nonischemic etiology. Age of relatives at time of death and cause of death were also noted. The assessment of the FH was based on the patient's or relatives' description and, when necessary, from the family doctor's notes.
We defined nonfatal and fatal acute coronary events in probands with published criteria, as reported previously, [22] [23] [24] based on the availability of history, ECG findings, cardiac biomarkers, autopsies, or death certificates. We defined ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI) by using standard criteria [22] [23] [24] as previously published. Troponin I was measured with the Bayer Centaur assay (Bayer HealthCare Diagnostics Division, Tarrytown, NY) according to the manufacturer's standard range.
ECGs were assessed by objective measurements based on the Minnesota criteria, but formal blinded Minnesota coding was not done. Unstable angina was defined as new cardiac symptoms or a changing symptom pattern with positive ECG findings, a positive stress test, or a relevant ischemic substrate on coronary angiography with or without subsequent percutaneous coronary intervention. [22] [23] [24] Events with a suggestive clinical presentation but without any of these additional features were classified as probable unstable angina, if that was the final diagnosis made by the managing clinician. Out-of-hospital sudden cardiac deaths were coded according to recommendations for epidemiological studies 25 and needed a definite history of preceding symptoms consistent with acute coronary ischemia, or postmortem evidence of either clinically significant coronary atherosclerosis or acute thrombosis, or a recorded myocardial infarction during the previous 28 days. 23, 24 However, to limit cases with missing data, out-of-hospital sudden cardiac deaths were excluded from our analyses.
A separate analysis of incident cases (first-ever in a lifetime event) was conducted to allow study of the effect of family history of MI on the age of onset of first symptomatic event.
A comprehensive search of general practice letters, cardiology outpatient clinic letters, coronary catheterization laboratory, hospital coding, and the DATACAM system in the John Radcliffe Hospital allowed identification of all the enrolled patients presenting with incident ACS who had undergone coronary angiography in the first 5 years of the OXVASC study. The coronary angiograms were reviewed by 2 independent interventional cardiologists (A.B. and C.L.). The presence of multivessel disease (defined as Ն50% stenosis in 2 or more of the 4 major coronary arteries: left main stem, left anterior descending, circumflex, and right coronary) was noted.
Statistical Analysis
Categorical variables were compared with Pearson 2 test, Fisher 2-tailed test, or McNemar 2 test where appropriate. Continuous variables were compared with 2-tailed t tests or analysis of variance where appropriate. Odds ratios (ORs) were calculated for positive FH of stroke in probands with ACS in 2 ways: (1) "maternal history versus paternal history" for male and female probands separately and (2) "female proband versus male proband" for family history of stroke by each type of FDR.
ORs were generally reported as "female versus male proband." In the comparison between the prevalence of maternal and paternal history of stroke, to avoid confounding due to any differences in characteristics between male and female probands, we used a paired analysis with ORs simply being the ratio between the number of probands with a maternal history of stroke and the number of those with a paternal history. Patients were included in the analyses if any relevant FH in FDRs was available. For example, if sibling history was available but parental history was absent, then that patient was included in the analyses regarding siblings and excluded from analyses regarding parental data. In paired analyses of data for the mother and father, only patients from whom history of both parents was known were included. The Mantel-Haenszel method was used to test heterogeneity between odds ratios for female and male probands.
Results
A total of 1058 patients with 1257 ACS were enrolled. Adequate FH data for stroke and MI were unavailable for 116 (11.0%) patients, most commonly due to cognitive impairment, rapid clinical deterioration before assessment, absence of informative relative, or adoption. Nine hundred forty-two patients had complete FH and were therefore included in the analysis (314 females and 628 males): 482 NSTEMI, 246 STEMI, and 214 unstable angina events (only collected for the first 2 years of the study) ( Table 1) . A total of 1152 patients with 1433 stroke/TIA events were enrolled for comparison with the ACS probands; 1015 stroke/TIA patients had complete FH and were included in the analyses.
Compared with males, female ACS probands were older, were slightly more likely to have had unstable angina as a qualifying event, and were more likely to have had a history of hypertension and cerebrovascular disease. Women were less likely to be current smokers. There were no significant differences between the sexes in prior use of antithrombotic and statin therapy. After adjustment for age, smoking (PϽ0.0001), history of stroke or TIA (Pϭ0.01), and history of cardiac failure (Pϭ0.03) remained significantly associated with the sex of the proband ( Table 1) .
The total number of siblings of ACS probands was 2639, with a median of 2 siblings (interquartile range, 1 to 4) for both male and female ACS probands. The mean age of mothers at death was similar in male and female probands (73.5 years; SD, 14.7 versus 72.5 years; SD, 16.4; Pϭ0.448), as was the mean age of fathers at death (68.6 years; SD, 13.5 versus 69.2 years; SD, 15.5; Pϭ0.591). The analyses given below are for all probands with any ACS (unstable angina, NSTEMI, or STEMI).
One hundred sixty-eight (17.8%) ACS probands and 237 (23.3%) stroke/TIA probands had a history of stroke in at least 1 parent, whereas 324 (34.4%) ACS probands and 321 stroke/TIA probands (31.6%) had a history of MI in at least 1 parent (Table 2) . Two hundred twenty-seven (24.1%) ACS probands and 247 (24.3%) stroke/TIA probands had history of stroke in Ն1 FDRs (parents or siblings); 493 (52.3%) ACS probands and 337 (33.2%) stroke/TIA probands had history of MI in Ն1 FDR.
There was sex-specific familial clustering across different vascular beds. Maternal stroke was more common than paternal stroke in female ACS probands (OR, 2.53; 1.39 to 4.61; Pϭ0.003 and OR, 2.59; 1.26 to 4.85; Pϭ0.006 in incident ACS cases) but not in male ACS probands (OR, 0.92; 0.64 to 1.32; Pϭ0.64 and OR, 0.87; 0.58 to 1.32; Pϭ0.53 in incident cases) ( Table 3 ; heterogeneity Pϭ0.004). Female ACS probands were more likely to have female siblings with stroke than male siblings with stroke (OR, 1.65; 0.67 to 4.04; Pϭ0.27) (Table 3) , whereas male ACS probands were more likely to have male siblings with stroke than female siblings with stroke (OR, 3.89; 1.77 to 8.55; Pϭ0.0003) (heterogeneity Pϭ0.002).
Similarly, female ACS probands were more likely to have female FDRs with stroke than male FDRs with stroke (OR, 2.09; 1.29 to 3.37; Pϭ0.002) ( Table 3) , whereas male ACS probands were more likely to have male FDRs with stroke than female FDRs with stroke (OR, 1.44; 1.03 to 2.01; 0.03) (heterogeneity Pϭ0.0002). The age at first stroke was similar in fathers and mothers (69.5Ϯ10.8 years versus 70.9Ϯ13.1 years, respectively), and there was no correlation between age of proband at ACS and age of father at time of stroke (rϭϪ0.147; Pϭ0.514 and rϭ0.260; Pϭ0.07 in female and male probands, respectively) or age of mother at stroke (rϭϪ0.015; Pϭ0.928 and rϭϪ0.145; Pϭ0.309 in female and male probands, respectively). The mean maternal and paternal age (SD) at time of MI (69.4Ϯ12.0 versus 65.6Ϯ11.5) was slightly lower than mean maternal and paternal age (SD) at time of stroke (70.9Ϯ13.1 years versus 69.5Ϯ10.8 years) in all ACS probands.
There were no statistically significant differences in baseline characteristics between those ACS probands with parental history and those probands without parental history of stroke. Only minor differences were found when probands with maternal history of stroke were compared with probands with paternal history of stroke (Table 4 ).
Three hundred fifty-one of 623 ACS probands from the first 5 years of the OXVASC study underwent coronary angiography; 59.0% (49/83) of women and 75.6% (201/266) of men had multivessel disease. FH of stroke was not associated with multivessel disease or with location of disease on coronary angiography, even when sex of the parent was considered ( Table  5 ). FH was not associated with any differences in clinical characteristics or peak troponin I levels (data not shown).
Discussion
Previous analyses of OXVASC data have shown that premature maternal MI was strongly associated with premature ACS and premature MI in female probands. 9 In addition, maternal history of stroke increases risk of stroke in women, 19 and family history of stroke may be a stronger predictor of risk of MI than risk of ischemic stroke. 17 We now show that maternal stroke is also a risk factor for MI in women. In men, a maternal history of MI has been shown to be less important than a paternal history of MI, 9 and our findings suggest that the same is true for maternal history of stroke. Previous studies have considered a sex-ofparent effect for FH of MI in MI probands, 26, 27 but none have considered FH of stroke in MI probands or been truly population-based or studied sex-of-proband/sex-of-parent effects. 1, 2, 17, 26, 27 Our FH study is also the first to consider the full spectrum of ACS without age restrictions on the proband or parent at time of vascular event.
Coronary angiographic data did not show any association between parental history of stroke and presence of multivessel disease or localization of disease in the coronary arteries ( Table 4 ), suggesting that maternal stroke affects ACS in females by a mechanism unrelated to atherosclerosis or coronary anatomy, perhaps being associated with thrombosis. These findings are consistent with studies looking for localization of cerebral arterial disease or stroke subtype in relation to the mother-daughter transmission of stroke. 28 There are several possible explanations for the excess of maternal stroke versus paternal stroke in ACS probands.
First, females tend to report FH more accurately than males in some diseases. 29 However, it is unlikely that maternal history of stroke is remembered quite so preferentially over paternal history of stroke and no such difference in recall was found in the Framingham Offspring Study. 3 Second, nonpaternity (usually ranging from 1% to 10%) and family breakdown may explain small differences in maternal versus paternal history of stroke, but such a large effect is very difficult to explain in this way. Moreover, nonpaternity cannot explain the large (4-fold) sex-specific difference between male and female siblings in male ACS probands (Table 3) . A third explanation involves the "Carter effect," 30 which occurs in diseases (or their intermediate phenotypes) that one sex is less prone to develop, such as MI, which is less common in women. 9, 30 Women with MI are likely to have required a greater number of genetic risk factors than men for MI to have occurred and would therefore transmit more MI susceptibility genes to their children than men with MI, which effect would be again most clearly manifest in female offspring. If there were shared risk factors between MI and stroke, a Carter effect might be expected for FH of stroke in ACS probands. Previous data support the Carter effect for the role of maternal MI in ACS probands, 9 but due to the much smaller sex difference in incidence, not for the role of maternal stroke in stroke/TIA probands, 19 which is more likely to be explained by epigenetic or genetic mechanisms. 19 Interestingly, genomewide scans have recently revealed that a locus on chromosome 10q11.21 showed a stronger association with coronary artery disease in women than men, and this locus is known to have a role in coding for the mitochondrial genome. 31 Finally, the sex-specific associations between stroke in FDRs and ACS in probands might be explained by either sex-specific genes or sex-specific behaviors which predispose to vascular disease across arterial territories.
The reliability of reported FH of MI has been shown to have 70% sensitivity and Ͼ95% specificity. 32, 33 Our previous validation study in the OXVASC cohort showed 83.3% sensitivity and 100%.specificity. 9 As previously noted, the way in which ORs are calculated in FH studies is crucial in determining their value in prediction of future coronary events. The definition of a premature event, the age at event in the patient and affected FDRs, and the sex of the patient and affected FDRs all influence calculated ORs.
In conclusion, this is the first time that an excess of maternal stroke in female versus male probands with ACS has been reported. Stroke in female FDRs may therefore be a risk factor for MI in women. Despite lower age-specific incidence of MI than men, women have higher case-fatality and are less aware than men of the risk carried by a FH of MI. 15 However, FH of cardiovascular disease is underused in clinical practice, 8 and existing risk prediction tools for MI either neglect FH or include it as a binary variable. 9 Traditional risk factors do not explain all coronary events in women, and even tools designed for risk prediction in women 16, 17 do not identify all women who subsequently go on to have MI. 18 Therefore, sex-specific differences in FH of MI and stroke may contribute to this unmet need for improved risk prediction in women. Future analyses should consider sex-of-parent/sex-ofoffspring associations in prospective studies to better understand how sex-specific differences in FH lead to sex-specific differences in pathogenesis (such as localization of disease on coronary angiography and prothrombotic markers) and outcomes of CHD. Genome-wide scans are yet to produce data that can be used for clinical risk prediction of vascular disease and more detailed use of FH data may provide a low-cost, low-technology alternative in the interim. LMS indicates left main stem; LAD, left anterior descending; Cx, circumflex; RCA, right coronary artery; multivessel disease, Ն50% stenosis in Ն2 coronary arteries; and any disease, Ն50% stenosis in any coronary arterial territory.
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*Probands with no FH versus probands with FH mother/father ( 2 test).
CLINICAL PERSPECTIVE
Family history of myocardial infarction (MI) and family history of stroke are important risk factors for MI, but they are seldom included in risk prediction tools. Within the Oxford Vascular Study, we have previously shown that history of maternal MI is twice as common in women with premature acute coronary syndrome (ACS) as in men with premature ACS and that excess mother-daughter transmission also occurs in ischemic stroke. No published studies have considered sex-of-parent/sex-of-proband interactions in the context of family history of stroke in ACS. We now show that family history of stroke is as common in ACS patients as in stroke/transient ischemic attack patients, and sex-of-parent/sex-of-proband interactions are similar. Maternal stroke is twice as common as paternal stroke in women with ACS but not in men with ACS. Women with ACS are more likely to have female first-degree relatives and men with ACS are more likely to have male first-degree relatives with stroke. Regardless of the mechanism of this sex-specific familial clustering across vascular beds, stroke in female first-degree relatives may help to identify women at increased risk of ACS as well as ischemic stroke. Women with family history of MI or stroke in female first-degree relatives should be emphasized in primary prevention strategies for coronary heart disease.
